Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice

Journal of Comparative Neurology

Volumn 521, Issue 6, 2013, Pages 1395-1408

  Couch, Brian A ^a   Kerrisk, Meghan E ^a   Kaufman, Adam C ^a   Nygaard, Haakon B ^a,b   Strittmatter, Stephen M ^a,b   Koleske, Anthony J ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Hippocampus; Novel object recognition; Presenilin 1; Radial arm water maze; Strain background

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; FOREBRAIN; MAZE TEST; MEMORY DISORDER; MOUSE; MOUSE STRAIN; NONHUMAN; OUTCROSSING; PRIORITY JOURNAL; PROTEIN PROCESSING; RECOGNITION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, OUTBRED STRAINS; FEMALE; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, 129 STRAIN; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; PLAQUE, AMYLOID; PRESENILIN-1; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84874160400     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23239     Document Type: Article

References (63)

1. Alamed J, Wilcock DM, Diamond DM, Gordon MN, Morgan D. 2006. Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nat Protoc 1: 1671-1679.
2. Anderton BH, Callahan L, Coleman P, Davies P, Flood D, Jicha GA, Ohm T, Weaver C. 1998. Dendritic changes in Alzheimer's disease and factors that may underlie these changes. Prog Neurobiol 55: 595-609.
3. Bertram L, Tanzi RE. 2008. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9: 768-778.
4. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS. 1997. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19: 939-945.
5. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
6. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George Hyslop P, Selkoe DJ. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3: 67-72.
7. Clark RE, Zola SM, Squire LR. 2000. Impaired recognition memory in rats after damage to the hippocampus. J Neurosci 20: 8853-8860.
8. Coleman P, Federoff H, Kurlan R. 2004. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63: 1155-1162.
9. Crawley JN. 1999. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835: 18-26.
10. Delatour B, Guegan M, Volk A, Dhenain M. 2006. In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol Aging 27: 835-847.
11. Diamond DM, Park CR, Heman KL, Rose GM. 1999. Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus 9: 542-552.
12. Dimou L, Schnell L, Montani L, Duncan C, Simonen M, Schneider R, Liebscher T, Gullo M, Schwab ME. 2006. Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci 26: 5591-5603.
13. Du AT, Schuff N, Kramer, JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW. 2007. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 130: 1159-1166.
14. Flood DG, Buell SJ, Horwitz GJ, Coleman PD. 1987. Dendritic extent in human dentate gyrus granule cells in normal aging and senile dementia. Brain Res 402: 205-216.
15. Franklin KB, Paxinos G. 2008. The mouse brain in stereotaxic coordinates. New York: Academic Press.
16. Fujii M, Hara H, Meng W, Vonsattel JP, Huang Z, Moskowitz MA. 1997. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke 28: 1805-1810; discussion 1811.
17. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP. 2006. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24: 516-524.
18. Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, Strittmatter SM. 2010. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30: 6367-6374.
19. Glazner KAC, Odero GL, Anema E, Motneko A, Schapansky J, Grossman D, Oliver DR, Glazner GW, Albensi BC. 2010. Strain specific differences in memory and neuropathlogy in a mouse model of Alzheimer's diesase. Life Sci 86: 942-950.
20. Halford RW, Russell DW. 2009. Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan. Proc Natl Acad Sci U S A 106: 3502-3506.
21. Hampel H, Burger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K. 2008. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 4: 38-48.
22. Hanks SD, Flood DG. 1991. Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease. I. CA1 of hippocampus. Brain Res 540: 63-82.
23. Hellström-Lindahl E, Viitanen M, Marutle A. 2009. Comparision of Abeta levels in the brain of familial and sporadic Alzheimer's diesase. Neurochem Int 55: 243-252.
24. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97-100.
25. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. 1999. Plaque-independent disruption of neural circuits in Alzheimer's diease mouse models. Proc Natl Acad Sci USA 96: 3228-3233.
26. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, et al. 1995. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15: 1203-1218.
27. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
28. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. 2001. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17: 157-165.
29. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13: 159-170.
30. Koleske AJ, Gifford AM, Scott ML, Nee M, Bronson RT, Miczek KA, Baltimore D. 1998. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21: 1259-1272.
31. Krezowski J, Knudson D, Ebeling C, Pitstick R, Giri RK, Schenk D, Westaway D, Younkin L, Younkin SG, Ashe KH, Carlson GA. 2004. Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression. Hum Mol Genet 13: 1989-1997.
32. Lassalle JM, Halley H, Dauman S, Verret L, Francés B. 2008. Effects of the genetic background on cognitive perfromances of TG2576 mice. Behav Brain Res 191: 104-110.
33. Lassmann H, Fischer P, Jellinger K. 1993. Synaptic pathology of Alzheimer's disease. Ann N Y Acad Sci 695: 59-64.
34. Lee I, Hunsaker MR, Kesner RP. 2005. The role of hippocampal subregions in detecting spatial novelty. Behav Neurosci 119: 145-153.
35. Lehman EJ, Kulnane LS, Gao Y, Petriello MC, Pimpis KM, Younkin L, Dolios G, Wang R, Younkin SG, Lamb BT. 2003. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Hum Mol Genet 12: 2949-2956.
36. McClean PL, Parthsarathy V, Faivre E, Holscher C. 2011. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 31: 6587-6594.
37. McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler DJ Jr, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM. 2009. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 251: 195-205.
38. Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L, Penke B, Zilberter Y, Harkany T, Pitkanen A, Tanila H. 2009. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29: 3453-3462.
39. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tastsuno G, Hu K, Kholodenko D, Johnson-Wood, K, McConlogue L. 2000. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20: 4050-4058.
40. O'Brien RJ, Wong PC. 2011. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34: 185-204.
41. Ozmen L, Albientz A, Czech C, Jacobsen H. 2009. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice. Neurodegener Dis 6: 29-26.
42. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. 2007. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55: 697-711.
43. Park JH, Widi GA, Gimbel DA, Harel NY, Lee DH, Strittmatter SM. 2006. Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci 26: 13279-13286.
44. Price DL, Tanzi RE, Borchelt DR, Sisodia SS. 1998. Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet 32: 461-493.
45. Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D. 2007. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav Brain Res 178: 18-28.
46. Reiserer RS, Harrison FE, Syverud DC, McDonald MP. 2007. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav 6: 54-65.
47. Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, Ellis TA, Waring JF, Decker MW, Rueter LE, Browmann KE. 2010. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease. Brain Res 1131: 136-147.
48. Ryman D, Lamb BT. 2006. Genetic and environmental modifiers of Alzhimer's disease phenotypes in the mouse. Curr Alzheimer Res 3: 465-473.
49. Scheff SW, Sparks DL, Price DA. 1996. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia 7: 226-232.
50. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. 2007. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68: 1501-1508.
51. Sebastiani G, Krzywkowski P, Dudal S, Yu M, Paquette J, Malo D, Gervais F, Tremblay P. 2006. Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice. Hum Mol Genet 15: 2313-2323.
52. Sfakianos MK, Eisman A, Gourley SL, Bradley WD, Scheetz AJ, Settleman J, Taylor JR, Greer CA, Williamson A, Koleske AJ. 2007. Inhibition of Rho via Arg and p190RhoGAP in the postnatal mouse hippocampus regulates dendritic spine maturation, synapse and dendrite stability, and behavior. J Neurosci 27: 10982-10992.
53. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. 2012. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15: 1227-1235.
54. Uylings HB, de Brabander JM. 2002. Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn 49: 268-276.
55. Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C, Mercken M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F. 2000. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am J Pathol 157: 1283-1298.
56. Van Petten C. 2004. Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. Neuropsychologia 42: 1394-1413.
57. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid beta protein potentely inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.
58. Wellons JC 3rd, Sheng H, Laskowitz DT, Burkhard Mackensen G, Pearlstein RD, Warner DS. 2000. A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia. Brain Res 868: 14-21.
59. Westermark GT, Johnson KH, Westermark P. 1999. Staining methods for identification of amyloid in tissue. Methods Enzymol 309: 3-25.
60. Wilcock DM, Alamed J, Gottschall PE, Grimm J, Rosenthal A, Pons J, Ronan V, Symmonds K, Gordon MN, Morgan D. 2006. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. J Neurosci 26: 5340-5346.
61. Xavier GF, Costa VC. 2009. Dentate gyrus and spatial behaviour. Prog Neuropsychopharmacol Biol Psychiatry 33: 762-773.
62. Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Mian J, Li Z. 2011. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe-PS1dE9 mouse model of Alzheimer's disease. Behav Brain Res 222: 342-350.
63. Zola SM, Squire LR, Teng E, Stefanacci L, Buffalo EA, Clark RE. 2000. Impaired recognition memory in monkeys after damage limited to the hippocampal region. J Neurosci 20: 451-463.